Sector consensus Merck KGaA

Stocks

Market Closed - Xetra Other stock markets 09:05:14 13/07/2026 pm IST			After hours 01:29:59 am
139.85 ^EUR	+0.11%		139.38	-0.34%

09/07	Merck Receives FDA Breakthrough Therapy Designation For Enpatoran In Lupus Patients With Active Skin Manifestations	CI
08/07	Merck KGaA's Lupus Drug Gets US FDA Breakthrough Therapy Designation	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Analysts' Target price divergence	Average Target P.	Objective/dr gap	Nbr of analysts
MERCK KGAA			145.86	+4.41%	14
MERCK & CO., INC.			132.33	+7.12%	27
HALOZYME THERAPEUTICS, INC.			83.9	+10.1%	10
KYOWA KIRIN CO., LTD.			2,227.27	-15.67%	11
SK BIOPHARMACEUTICALS CO., LTD.			1,34,909.09	+63.72%	11
BETTA PHARMACEUTICALS CO., LTD.	-	-	43.06	-34.62%	1
YUHAN CORPORATION			1,27,555.56	+86.21%	18
SUPERNUS PHARMACEUTICALS, INC.			63.5	+31.04%	6
SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.	-	-	-	-	-
KISSEI PHARMACEUTICAL CO., LTD.			4,833.33	+17.89%	6
ETON PHARMACEUTICALS, INC.			45.67	+24.74%	3
DBV TECHNOLOGIES			3.8	+33.24%	3
Average			24,549.4	+20.74%	10
Weighted average by Cap.			2,659.05	+7.38%	23